Aerial BioPharma, LLC   Report issue

Contributed to NME For profit Phase 2
Founded: Morrisville NC United States (2011)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2011
NCT01485770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

solriamfetol (Sunosi) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Narcolepsy (Phase 2)

Sleepiness (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1